ARMISTICE CAPITAL LLC 13D and 13G filings for InVivo Therapeutics Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:53 pm Sale |
2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
ARMISTICE CAPITAL LLC | 163,100 4.990% |
-81,899 (-33.43%) |
Filing |
| 2023-02-14 1:13 pm Purchase |
2022-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
ARMISTICE CAPITAL LLC | 244,999 9.990% |
244,999 (New Position) |
Filing |